Source study found

Story checked

Taking antibiotics? Sugar may be making the damage worse | ScienceDaily (opens in a new tab)

sciencedaily.com · 2026-10-07

Short answerEvidenceSource

Short answer

Mixed

Mixed.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

2 supported
4 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail

The story

Taking antibiotics? Sugar may be making the damage worse | ScienceDaily

sciencedaily.com · 2026-10-07

The story’s checkable claims.

Read the original story

NewsLink checks it

Mixed

Every claim we could check holds up. Two of six claims match the study. This overall rating is based only on the claims we could check. Four claims the study doesn't address.

2 supported
4 not covered

Open claim evidence

The source study

Sugar-rich foods exacerbate antibiotic-induced microbiome disruption

Nature · 2026

Open source record Open in Tessa

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

Reading mode

Scan verdicts. Open evidence only when needed.

Browse by verdict

6 claims in this story

Showing all 6 claimsChoose a verdict to focus the list.

Claim 1 of 6Not coveredResearchers from NYU Langone Health, City of Hope, and Memorial Sloan Kettering monitored 9,419 meals consumed by 173 hospitalized cancer patients and tracked changes in their gut microbiomes.View evidenceHide evidence

As stated9,419 meals; 173 hospitalized cancer patients

Why this verdict

The profile supports the core numbers that 9,419 meals from 173 hospitalized HCT patients were tracked and microbiome changes analyzed. However, the named institutions are not available in the supplied abstract-level profile, and the profile specifies HCT patients with paired microbiome inference in 158 patients rather than simply '173 hospitalized cancer patients' for all microbiome inference.

Study evidence

Higher intake of sweets and sugars during antibiotic exposure was associated with greater loss of gut microbiome α-diversity in hospitalized HCT patients.

“precisely tracking 9,419 meals consumed by 173 patients who were hospitalized for haematopoietic cell transplantation and analysing subsequent microbiome changes”

Claim 2 of 6Not coveredFor every additional 100 grams of sugar eaten during the 48 hours before treatment, the researchers observed an additional 21% decline in alpha diversity.View evidenceHide evidence

As stated21% decline in alpha diversity per additional 100 grams of sugar

Why this verdict

The profile supports the general association between higher sweets/sugar intake during antibiotic exposure and greater alpha-diversity loss, but the abstract-level evidence explicitly lacks quantitative effect sizes and timing details. The stated 21% decline per additional 100 grams of sugar during the prior 48 hours cannot be verified from the supplied profile.

Study evidence

Higher intake of sweets and sugars during antibiotic exposure was associated with greater loss of gut microbiome α-diversity in hospitalized HCT patients.

“precisely tracking 9,419 meals consumed by 173 patients who were hospitalized for haematopoietic cell transplantation and analysing subsequent microbiome changes”

Claim 3 of 6Not coveredSugary diets combined with antibiotic treatment were associated with increases in Enterococcus faecium among patients.View evidenceHide evidence

Why this verdict

The abstract-level profile supports an association between higher sweets/sugar intake during antibiotic exposure and greater Enterococcus expansion in patients. It does not verify the species-level claim of Enterococcus faecium; it reports Enterococcus at the genus level.

Study evidence

Higher intake of sweets and sugars during antibiotic exposure was associated with greater loss of gut microbiome α-diversity in hospitalized HCT patients.

“precisely tracking 9,419 meals consumed by 173 patients who were hospitalized for haematopoietic cell transplantation and analysing subsequent microbiome changes”

Claim 4 of 6Not coveredMouse experiments produced a similar result: animals exposed to the antibiotic biapenem while consuming dietary sucrose experienced a 16.3-fold increase in gut Enterococcus by day 3 and a 33.4-fold higher bacterial burden by day 6.View evidenceHide evidence

As stated16.3-fold by day 3; 33.4-fold by day 6

Why this verdict

The profile supports the general mouse finding that sucrose supplementation increased and prolonged antibiotic-induced Enterococcus expansion. But the abstract-level profile does not provide the antibiotic name biapenem, the day-3/day-6 timing, or the 16.3-fold and 33.4-fold quantitative effects.

Study evidence

Dietary sucrose supplementation increased and prolonged antibiotic-induced Enterococcus expansion in mice.

“Experiments in mice also showed that sucrose supplementation increased and prolonged antibiotic-induced Enterococcus expansion.”

Claim 5 of 6SupportedEating more sugar while taking antibiotics may intensify the disruption those drugs cause to beneficial gut bacteria.View evidenceHide evidence

Why this verdict

The abstract-level profile supports an associational, hedged claim that higher sweets/sugar intake during antibiotic exposure predicted exacerbated gut microbiome dysbiosis, including lowered alpha-diversity. The headline wording uses 'may' and does not clearly outrun the body’s caveated framing.

Study evidence

Higher intake of sweets and sugars during antibiotic exposure was associated with greater loss of gut microbiome α-diversity in hospitalized HCT patients.

“precisely tracking 9,419 meals consumed by 173 patients who were hospitalized for haematopoietic cell transplantation and analysing subsequent microbiome changes”

Claim 6 of 6SupportedThe researchers suggest that cutting back on simple sugars during and after antibiotic treatment could potentially reduce microbiome damage, but they say more work is needed to determine the mechanism and whether dietary changes improve outcomes in patients.View evidenceHide evidence

Why this verdict

The profile’s discussion supports the authors’ speculative suggestion that avoiding a high-simple-sugar diet during antibiotic treatment may reduce antibiotic-associated microbiota disruption, and it notes the need for further studies to generalize and evaluate interventions. The story’s hedging and statement that patient-outcome benefits remain to be tested are consistent with the supplied profile, though the exact 'during and after' and 'clinical trials' wording is more specific than the abstract-level profile.

Study evidence

Higher intake of sweets and sugars during antibiotic exposure was associated with greater loss of gut microbiome α-diversity in hospitalized HCT patients.

“precisely tracking 9,419 meals consumed by 173 patients who were hospitalized for haematopoietic cell transplantation and analysing subsequent microbiome changes”

Study evidence

Dietary sucrose supplementation increased and prolonged antibiotic-induced Enterococcus expansion in mice.

“Experiments in mice also showed that sucrose supplementation increased and prolonged antibiotic-induced Enterococcus expansion.”

Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

Bayesian inference used paired longitudinal microbiome samples from 158 patients for the main human microbiome association analysis.
The story states that 173 patients were monitored but does not mention that the profile identifies 158 patients with paired longitudinal microbiome samples as the inference set.
From observational longitudinal cohort
The patient population is a specific hospitalized HCT population, so external generalizability is uncertain without further study.
The story limits the setting to hospitalized cancer or blood-cancer patients, but it does not clearly identify HCT patients or mention uncertainty about generalizing beyond that clinical population.
From observational longitudinal cohort
Mouse-model findings may not directly generalize to humans, and the abstract lacks mouse regimen, dose, sample-size, and quantification details.
The story notes that patient clinical trials are still needed, but it does not specifically caveat the animal-model generalizability or the missing methodological details for the mouse experiment at abstract depth.
From in_vivo_mouse_dietary_supplementation_with_antibiotics

6 things the story did carry across

Human longitudinal cohort: 9,419 meals were tracked in 173 hospitalized haematopoietic cell transplantation patients, with subsequent gut microbiome changes analyzed.
Higher sweets/sugar intake during antibiotic exposure was associated with lowered alpha-diversity in the human cohort.
Higher sweets/sugar intake during antibiotic exposure was associated with greater Enterococcus expansion in the human cohort.
Mouse experiments found that dietary sucrose supplementation increased and prolonged antibiotic-induced Enterococcus expansion.
The authors suggest avoiding high simple-sugar intake during antibiotic treatment may reduce microbiota disruption, but interventions require further validation.
Human findings are observational and do not establish causality; residual confounding is possible.

Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoQuantify, in hospitalized haematopoietic cell transplantation patients, how intake of sweets/sugars during antibiotic exposure associates with longitudinal gut microbiome disruption (α-diversity loss and Enterococcus expansion).observational longitudinal cohortExpand

In plain English

In a longitudinal cohort of hospitalized haematopoietic cell transplantation patients with precise meal tracking (9,419 meals in 173 patients) and paired longitudinal microbiome samples (158 patients), Bayesian analysis found that intake of sweets/sugars during antibiotic exposure was associated with exacerbated microbiome dysbiosis, specifically reduced α-diversity and increased Enterococcus abundance.

Key findings

Higher intake of sweets and sugars during antibiotic exposure was associated with greater loss of gut microbiome α-diversity in hospitalized HCT patients.
Higher intake of sweets and sugars during antibiotic exposure was associated with greater expansion of Enterococcus in the gut microbiome.

“precisely tracking 9,419 meals consumed by 173 patients who were hospitalized for haematopoietic cell transplantation and analysing subsequent microbiome changes”

What this piece can’t prove

Observational design during clinical care of HCT patients limits causal interpretation; residual confounding possible.
Cohort is a specific hospitalized HCT population; external generalizability is uncertain.

2 further details could not be confirmed from the summary.

2in vivo animalTest causality/mechanism in an animal model: determine whether dietary sucrose supplementation worsens and prolongs antibiotic-induced Enterococcus expansion in mice.in vivo mouse dietary supplementation with antibioticsExpand

In plain English

In a mouse in vivo experiment, dietary sucrose supplementation given during antibiotic exposure caused an increased and prolonged expansion of Enterococcus compared with antibiotic exposure without sucrose.

Key findings

Dietary sucrose supplementation increased and prolonged antibiotic-induced Enterococcus expansion in mice.

“Experiments in mice also showed that sucrose supplementation increased and prolonged antibiotic-induced Enterococcus expansion.”

What this piece can’t prove

Limited methodological detail in abstract (no sucrose dose, antibiotic type/duration, mouse strain, sample size, or quantification method reported).
Results are from an animal model and may not directly generalize to humans without further validation.

Finally, the search trail

Method layer